GLUE
Monte Rosa Therapeutics, Inc.
NASDAQ · Healthcare · Biotechnology · US
$13.84
−3.76%0
Insider buys (3m)
13
Insider sells (3m)
-$2.0M
Net value (3m)
-14.4%
Price return (3m)
Form 4 filings
| Date | Insider | Activity | Shares | Price |
|---|---|---|---|---|
| Jul 17, 2026 | Warmuth Markus · director, officer: President & CEO | Sale | 9,500 | $23 |
| Jul 16, 2026 | Champoux Jennifer · officer: Chief Operating Officer | Sale | 4,351 | $23 |
| Jul 16, 2026 | Champoux Jennifer · officer: Chief Operating Officer | M-Exempt | 4,351 | $3.98 |
| Jul 7, 2026 | Townson Sharon · officer: Chief Scientific Officer | M-Exempt | 6,000 | $6.14 |
| Jul 7, 2026 | Townson Sharon · officer: Chief Scientific Officer | Sale | 5,600 | $23 |
| Jul 7, 2026 | Townson Sharon · officer: Chief Scientific Officer | Sale | 400 | $24 |
| Jul 1, 2026 | Janku Filip · officer: Chief Medical Officer | M-Exempt | 5,407 | $13 |
| Jul 1, 2026 | Janku Filip · officer: Chief Medical Officer | Sale | 5,407 | $25 |
| Jun 30, 2026 | Manning Anthony M. · director | M-Exempt | 10,000 | $4.16 |
| Jun 30, 2026 | Janku Filip · officer: Chief Medical Officer | M-Exempt | 6,000 | $7.56 |
| Jun 30, 2026 | Janku Filip · officer: Chief Medical Officer | Sale | 6,000 | $23 |
| Jun 30, 2026 | Manning Anthony M. · director | Sale | 10,000 | $23 |
| Jun 25, 2026 | Champoux Jennifer · officer: Chief Operating Officer | M-Exempt | 2,175 | $3.98 |
| Jun 25, 2026 | Champoux Jennifer · officer: Chief Operating Officer | Sale | 2,175 | $20 |
| Jun 25, 2026 | Townson Sharon · officer: Chief Scientific Officer | M-Exempt | 3,000 | $6.14 |
| Jun 25, 2026 | Townson Sharon · officer: Chief Scientific Officer | Sale | 3,000 | $20 |
| Jun 25, 2026 | Janku Filip · officer: Chief Medical Officer | M-Exempt | 6,000 | $7.56 |
| Jun 25, 2026 | Janku Filip · officer: Chief Medical Officer | Sale | 11,845 | $20 |
| Jun 25, 2026 | Janku Filip · officer: Chief Medical Officer | M-Exempt | 30,000 | $7.56 |
| Jun 25, 2026 | Janku Filip · officer: Chief Medical Officer | Sale | 30,000 | $21 |
| Jun 18, 2026 | Champoux Jennifer · officer: Chief Operating Officer | M-Exempt | 2,176 | $3.98 |
| Jun 18, 2026 | Champoux Jennifer · officer: Chief Operating Officer | Sale | 2,176 | $19 |
| Jun 18, 2026 | Townson Sharon · officer: Chief Scientific Officer | M-Exempt | 3,000 | $6.14 |
| Jun 18, 2026 | Townson Sharon · officer: Chief Scientific Officer | Sale | 3,000 | $19 |
| Jun 12, 2026 | Siu Christine · director | A-Award | 25,800 | $17 |
| Jun 12, 2026 | SCHIFF ANDREW N · director | A-Award | 25,800 | $17 |
| Jun 12, 2026 | Behbahani Ali · director | A-Award | 25,800 | $17 |
| Jun 12, 2026 | Blackwell Kimberly · director | A-Award | 25,800 | $17 |
| Jun 12, 2026 | Hughes Eric A · director | A-Award | 25,800 | $17 |
| Jun 12, 2026 | Skvarka Jan · director | A-Award | 25,800 | $17 |
Institutional positioning
13F filings over the trailing two quarters
New 81Increased 165Reduced 104Sold out 23
| Filer | Action | Shares | Filed |
|---|---|---|---|
| PRICE T ROWE ASSOCIATES INC /MD/ | Increased | 8,861,171 | Aug 14, 2026 |
| NEA MANAGEMENT COMPANY, LLC | Unchanged | 7,692,298 | May 15, 2026 |
| NEA Management Company, LLC | Unchanged | 7,692,298 | Aug 14, 2026 |
| BlackRock, Inc. | Increased | 6,843,087 | Aug 7, 2026 |
| PRICE T ROWE ASSOCIATES INC /MD/ | Increased | 6,720,188 | May 15, 2026 |
| BLACKROCK, INC. | Increased | 5,637,684 | May 13, 2026 |
| TCG CROSSOVER MANAGEMENT, LLC | Unchanged | 4,622,151 | May 15, 2026 |
| TCG Crossover Management, LLC | Unchanged | 4,622,151 | Aug 14, 2026 |
| Vestal Point Capital, LP | Increased | 4,600,000 | Aug 14, 2026 |
| BVF INC/IL | Increased | 4,460,886 | May 15, 2026 |
| BVF INC/IL | Unchanged | 4,460,886 | Aug 14, 2026 |
| BAKER BROS. ADVISORS LP | Unchanged | 4,345,736 | May 15, 2026 |
| BAKER BROS. ADVISORS LP | Unchanged | 4,345,736 | Aug 14, 2026 |
| SUVRETTA CAPITAL MANAGEMENT, LLC | Increased | 4,226,809 | May 15, 2026 |
| STATE STREET CORP | Increased | 3,731,416 | Aug 7, 2026 |
Insider activity from SEC Form 4; institutional positioning from 13F filings · Latest filing Jul 17, 2026